Charting the Course for Metastatic Breast Cancer Care Optimizing First-Line Treatment and Beyond CPD Friday, 17 October 2025 | 10:15 - 11:45 CEST HEIDELBERG AUDITORIUM, HALL 6.2, MESSE BERLIN, BERLIN, GERMANY

https://events.medscapelive.org/website/88295/ Navigate recent shifts in the landscape of metastatic breast cancer (mBC) alongside top international experts with this symposium designed to transform your clinical practice. This session will uncover the latest clinical data supporting novel and emerging treatment strategies, with a special focus on hormone receptor (HR)-positive/HER2-negative and HER2-positive disease subtypes. Through a combination of expert-to-expert debate, interactive sessions and panel discussions, you will gain in-depth insights on key topics such as expanding first-line treatment options for HR-positive mBC and groundbreaking advances in HER2-targeting. Leave this session with the know-how to chart a sturdier course around increasingly complex treatment algorithms, along with greater overall confidence in best practices for mBC management. Don't miss this unparalleled opportunity to enhance your clinical competence and optimize outcomes for patients living with mBC. https://events.medscapelive.org/website/88295/